A recent study used a cross-sectional analysis of a large cohort of patients with atrial fibrillation (AF) to investigate the relationship between chronic obstructive pulmonary disease (COPD) and AF to identify mediators of increased vascular risk; they found that the risk of cardiovascular complications is higher for patients with AF who also have COPD than it is for patients without COPD.
Atrial fibrillation (AF) is among the most commonly observed extrapulmonary manifestations of chronic obstructive pulmonary disease (COPD), and AF significantly impacts the risk of cardiovascular morbidity and mortality in patients with COPD, though the mechanisms underlying increased risk of vascular events and death associated with COPD and AF are not entirely understood.
One recent study used a cross-sectional analysis of a large cohort of patients with AF to investigate the relationship between COPD and AF, and to identify mediators of increased vascular risk; they found that the risk of cardiovascular complications is higher for patients with AF who also have COPD than it is for patients without COPD.
The study relied on data from the Umbria Atrial Fibrillation Registry, which includes patients with AF from 22 centers in Italy. In total, 2159 patients were included, and 15.6% of them had COPD as well as AF. Patients who had COPD along with AF were more likely to have obesity and to be current smokers. Other cardiovascular risk factors, such as diabetes and chronic kidney disease, as well as peripheral artery disease and subclinical atherosclerosis, were also more prevalent in patients with COPD.
Those who had COPD also had a higher prevalence of previous acute coronary syndrome, stroke/transient ischemic attack, and heart failure. Most notably, those with COPD had a much higher frequency of heart failure requiring hospitalization than those without COPD (40.9% versus 17.4%; P =.0001).
Also of note was the fact that 24.0% of patients with COPD had a history of anemia, versus 14.0% for those without COPD. Thromboembolic and bleeding risks were also higher in the COPD group.
Finally, patients with COPD were also more likely to have left ventricular hypertrophy than those without COPD (P = .018).
“Results of our cross-sectional analysis highlighted the notion that AF patients with COPD have a higher risk of cardio- and cerebrovascular complications than AF patients without this lung disease,” wrote the investigators. The results of the analysis suggest that early intervention for patients with COPD and AF should be implemented as a matter of urgency, they added.
Reference
Angeli F, Reboldi G, Trapasso M, Aita A, Ambrosio G, Verdecchia P. Detrimental impact of chronic obstructive pulmonary disease in atrial fibrillation: new insights from Umbria Atrial Fibrilation Registry. Medicina. 2019;55(7):358. doi: 10.3390/medicina55070358.
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
November 21st 2024Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
Read More
A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs
November 16th 2021On this episode of Managed Care Cast, we speak with MeiLan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the lungs and how they work, zooms out to examine the drivers of poor respiratory health, and addresses policy changes that are needed to improve lung health.
Listen
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks
October 23rd 2024Interstitial lung abnormalities (ILAs) in patients with chronic obstructive pulmonary disease (COPD) are linked to lower lung adenocarcinoma rates but higher rates of other cancers and heart failure.
Read More
Ineligibility, Limitations to PR Uptake in Patients With AECOPD
October 15th 2024Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) participated in post-discharge pulmonary rehabilitation (PR), with ineligibility significantly limiting uptake.
Read More